| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.26 | 1e-07 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.24 | 8e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.18 | 9e-05 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |